1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Hepatitis C Market & Forecast, Hepatitis C Pipeline Drugs Sales & Forecast, Clinical Trials - Global

Market for Hepatitis C drugs has grown with a phenomenal rate of more than US$ 13 Billion, in the year 2014 compared to 2013. In the last two years a couple of new drugs have been introduced in the market which has become a huge success and they have captured maximum market share of the Hepatitis C market. Gilead currently dominates the multi-billion dollar Hepatitis C market, but AbbVie has been trying to increase its market share since U.S. regulators approved the marketing of its Viekira Pak. Drug makers are already focusing on introducing new drugs in the market as several drugs are standing in the pipeline. Hepatitis C Drugs is anticipated to be a rosy market for future period.

This is 3rd edition report on Hepatitis C Drugs Industry by Renub Research. Report titled “Hepatitis C Market & Forecast, Hepatitis C Pipeline Drugs Sales & Forecast, Clinical Trials - Global” provides a comprehensive assessment of the fast-evolving, high-growth of Hepatitis sector. This 87 page report with 18 Figures and 1 Table studies the Hepatitis C Drug Market Landscape.

1. Hepatitis C Drugs Market & Forecast (Chapter 2)
2. Hepatitis C Approved Drugs Sales & Forecast (Chapter 3)
3. Hepatitis C – Pipeline Drugs Sales & Forecast (Chapter 4)
4. Hepatitis C Deals & Acquisitions (Chapter 5)
5. Hepatitis C – Company Wise Clinical Trial Analysis (Chapter 6)


Hepatitis C – Approved Drugs Sales & Forecast (To 2020) (Chapter No. 3)


1. Pegasys
2. Pegintron
3. Incivek
4. Victrelis
5. Olysio
6. Sovaldi/Harvoni
7. HCV Franchise
8. Viekira Pak

Hepatitis C – Pipeline Drugs Sales Forecast (To 2020) (Chapter No. 4)

1. Drug A (Merck & Co. Inc.)
2. Drug B (Merck & Co. Inc.)
3. Drug C (Bristol-Myers Squibb)


Hepatitis C – Company Wise Clinical Trial Analysis (Chapter No.5)

1. AbbVie
2. Bristol-Myers Squibb (BMS)
3. Gilead Sciences
4. Merck & Co. Inc.
5. Tibotec/Janssen Therapeutics


Data Sources

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts.

Primary sources include industry surveys and telephone interviews with industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.

Table Of Contents

Hepatitis C Market and Forecast, Hepatitis C Pipeline Drugs Sales and Forecast, Clinical Trials - Global
Table of Contents

1. Executive Summary

2. Hepatitis C Drugs - Market and Forecast

3. Hepatitis C - Approved Drugs Sales and Forecast
3.1 Pegasys Sales and Forecast
3.2 Pegintron Sales and Forecast
3.3 Incivek Sales
3.4 Victrelis Sales and Forecast
3.5 Olysio Sales and Forecast
3.6 Sovaldi / Harvoni Sales and Forecast
3.7 HCV Franchise Sales and Forecast
3.8 Viekira Pak Sales and Forecast

4. Hepatitis C - Pipeline Drugs Sales Forecast
4.1 Drug A of (Merck and Co. Inc.)
4.2 Drug B of (Merck and Co. Inc.)
4.3 Drug C of (Bristol-Myers Squibb)

5. Hepatitis C - Deals and Acquisitions

6. Hepatitis C - Company Wise Clinical Trials Analysis
6.1 AbbVie - Clinical Trials
6.1.1 Phase III
6.1.2 Phase II
6.1.3 Phase I
6.2 Bristol-Myers Squibb (BMS) - Clinical Trials
6.2.1 Phase III
6.2.2 Phase II
6.3 Gilead Sciences - Clinical Trials
6.3.1 Phase II
6.4 Merck and Co. Inc. - Clinical Trials
6.4.1 Phase IV
6.4.2 Phase III
6.4.3 Phase II
6.4.4 Phase I
6.5 Tibotec / Janssen Therapeutics - Clinical Trials
6.5.1 Phase IV
6.5.2 Phase III
6.5.3 Phase II
6.5.4 Phase I


List of Figures:

Figure 2 1: Global - Hepatitis C Drug Market (Million US$), 2010 - 2014
Figure 2 2: Global - Forecast for Hepatitis C Drug Market (Million US$), 2015 - 2020
Figure 3 1: Global - Pegasys Sales (Million US$), 2005 - 2014
Figure 3 2: Global - Forecast for Pegasys Sales (Million US$), 2015 - 2020
Figure 3 3: Global - Pegintron Sales (Million US$), 2010 - 2014
Figure 3 4: Global - Forecast for Pegintron Sales (Million US$), 2015 - 2020
Figure 3 5: Global - Incivek Sales (Million US$), 2011 - 2014
Figure 3 6: Global - Victrelis Sales and Forecast (Million US$), 2011 - 2015
Figure 3 7: Global - Olysio Sales (Million US$), 2013 - 2014
Figure 3 8: Global - Forecast for Olysio Sales (Million US$), 2015 - 2020
Figure 3 9: Global - Sovaldi/Harvoni Sales (Million US$), 2013 - 2014
Figure 3 10: Global - Forecast for Sovaldi/Harvoni Sales (Million US$), 2015 - 2020
Figure 3 11: Global - HCV Franchise Sales and Forecast (Million US$), 2014 - 2020
Figure 3 12: Hepatitis C Drugs - Viekira Pak, Sovaldi and Harvoni Initial Prescription (Number), 2013, 2014
Figure 3 13: Global - Viekira Pak Sales and Forecast (Million US$), 2014 - 2020

Figure 4 1: Global - Forecast for Vaniprevir (MK-7009) Sales (Million US$), 2015 - 2020
Figure 4 2: Global - Forecast for Grazoprevir/Elbasvir (MK-5172 + MK-8742) Sales (Million US$), 2016 - 2020
Figure 4 3: Global - Forecast for PEG-Interferon Lambda Sales (Million US$), 2015 - 2020

List of Tables:

Table 5 1: Hepatitis C - Deals and Acquisitions in the anti-HCV Drug Space, 2004 - 2012

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Hepatitis Viruses Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

Hepatitis Viruses Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

  • $ 4000
  • Industry report
  • December 2016
  • by Global Data

Hepatitis Viruses Diagnostic Tests - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Hepatitis Viruses Diagnostic Tests - Medical Devices Pipeline Assessment, ...

Hepatitis C-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Hepatitis C-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2000
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s Report, “Hepatitis C-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline ...

Hepatitis C Virus (HCV) Protease Inhibitors -Pipeline Insights, 2016

Hepatitis C Virus (HCV) Protease Inhibitors -Pipeline Insights, 2016

  • $ 1250
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s, “Hepatitis C Virus (HCV) Protease Inhibitors-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Hepatitis ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.